Zynex Valuation
ZYXI Stock | USD 2.31 0.04 1.70% |
Based on Macroaxis valuation methodology, the company appears to be undervalued. Zynex Inc maintains a prevalent Real Value of $3.12 per share. The last-minute price of the company is $2.31. Our model calculates the value of Zynex Inc from examining the company fundamentals such as Profit Margin of (0.04) %, return on asset of -0.0411, and Current Valuation of 118.13 M as well as analyzing its technical indicators and probability of bankruptcy.
Undervalued
Today
Please note that Zynex's price fluctuation is very risky at this time. Calculation of the real value of Zynex Inc is based on 3 months time horizon. Increasing Zynex's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Zynex is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Zynex Stock. However, Zynex's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. Historical | Market 2.31 | Real 3.12 | Hype 2.29 | Naive 2.0 |
The intrinsic value of Zynex's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Zynex's stock price.
Estimating the potential upside or downside of Zynex Inc helps investors to forecast how Zynex stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Zynex more accurately as focusing exclusively on Zynex's fundamentals will not take into account other important factors: Zynex Total Value Analysis
Zynex Inc is at this time anticipated to have valuation of 118.13 M with market capitalization of 69.85 M, debt of 73.82 M, and cash on hands of 23.53 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Zynex fundamentals before making equity appraisal based on enterprise value of the companyTakeover Price | Market Cap | Debt Obligations | Cash |
118.13 M | 69.85 M | 73.82 M | 23.53 M |
Zynex Investor Information
About 48.0% of the company outstanding shares are owned by insiders. The book value of Zynex was at this time reported as 0.69. The company recorded a loss per share of 0.24. Zynex Inc last dividend was issued on the 5th of January 2022. The entity had 11:10 split on the 5th of January 2022. Based on the key measurements obtained from Zynex's financial statements, Zynex Inc is not in a good financial situation at this time. It has a very high probability of going through financial hardship in August.Zynex Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Zynex has an asset utilization ratio of 157.57 percent. This signifies that the Company is making $1.58 for each dollar of assets. An increasing asset utilization means that Zynex Inc is more efficient with each dollar of assets it utilizes for everyday operations.Zynex Ownership Allocation
Zynex Inc retains a total of 30.24 Million outstanding shares. Zynex Inc owns significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Please note that no matter how many assets the company shows, if the real value of the company is less than the current market value, you may not be able to make money on it.Zynex Profitability Analysis
The company reported the previous year's revenue of 192.35 M. Net Income was 2.99 M with profit before overhead, payroll, taxes, and interest of 134.26 M.About Zynex Valuation
An absolute valuation paradigm, as applied to Zynex Stock, attempts to find the value of Zynex Inc based on its fundamental and basic technical indicators. By analyzing Zynex's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Zynex's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Zynex. We calculate exposure to Zynex's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Zynex's related companies.Zynex, Inc., through its subsidiaries, designs, manufactures, and markets medical devices to treat chronic and acute pain and activate and exercise muscles for rehabilitative purposes with electrical stimulation. Zynex, Inc. was founded in 1996 and is headquartered in Englewood, Colorado. Zynex operates under Medical Distribution classification in the United States and is traded on NASDAQ Exchange. It employs 774 people.
Zynex Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
Common Stock Shares Outstanding | 32.3 M | |
Quarterly Earnings Growth Y O Y | -0.3 | |
Forward Price Earnings | 16.6113 |
Complementary Tools for Zynex Stock analysis
When running Zynex's price analysis, check to measure Zynex's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Zynex is operating at the current time. Most of Zynex's value examination focuses on studying past and present price action to predict the probability of Zynex's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Zynex's price. Additionally, you may evaluate how the addition of Zynex to your portfolios can decrease your overall portfolio volatility.
Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
CEOs Directory Screen CEOs from public companies around the world | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Transaction History View history of all your transactions and understand their impact on performance | |
Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account |